Skip to main content

CORRECTION article

Front. Cell Dev. Biol., 17 November 2022
Sec. Signaling
Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.1090025

Corrigendum: Long non-coding RNAs as molecular biomarkers in cholangiocarcinoma

This article is a correction to:

  1. Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma

    1. Read original article
Yanhua WuYanhua Wu1Khizar HayatKhizar Hayat2Yufei HuYufei Hu1Jianfeng Yang, Jianfeng Yang3,4*
  • 1Department of Gastroenterology, The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China
  • 2Department of Gastroenterology, International Education College of Zhejiang Chinese Medical University, Hangzhou, China
  • 3Department of Gastroenterology, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • 4Key Laboratory of Integrated Traditional Chinese and Western Medicine for Biliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, China

A Corrigendum on
Long non-coding RNAs as molecular biomarkers in cholangiocarcinoma

by Wu Y, Hayat K, Hu Y and Yang J (2022). Front. Cell Dev. Biol. 10:890605. doi: 10.3389/fcell.2022.890605

In the published article, there was an error in Affiliation 1. Instead of “The Fourth Clinical College of Zhejiang Chinese Medicine University,” it should be “The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: cholangiocarcinoma, lncRNA, biomarker, diagnosis, prognosis, therapeutic target

Citation: Wu Y, Hayat K, Hu Y and Yang J (2022) Corrigendum: Long non-coding RNAs as molecular biomarkers in cholangiocarcinoma. Front. Cell Dev. Biol. 10:1090025. doi: 10.3389/fcell.2022.1090025

Received: 04 November 2022; Accepted: 07 November 2022;
Published: 17 November 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Wu, Hayat, Hu and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jianfeng Yang, eWpmMzMwM0B6anUuZWR1LmNu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.